Skip to main content
. Author manuscript; available in PMC: 2020 Dec 26.
Published in final edited form as: J Med Chem. 2019 Dec 10;62(24):11301–11323. doi: 10.1021/acs.jmedchem.9b01580

Table 5.

Preliminary Pharmacokinetic Screen of 2,6-Dimethyl-4-fluoro B-SERDs Compared to 2a

plasma concentration (nM)
brain concentration (nM)
compound 0.5 h 2 h 0.5 h 2h
2 31.2 ± 16.5 301 ± 268 0.7 ± 0.8b 47.4 ± 61.1
30f 786 ± 179 659 ± 329 750 ± 673 588 ± 274
30m 211 ± 45 163 ± 141 121 ± 61 276 ± 93
37d 2490 ± 797 2150 ± 201 1630 ± 1110 1250 ± 406
a

Plasma and brain concentration of 30f, 30m and 37d (100 mg/kg p.o.), and 2 (5 mg s.c.) showing mean and s.d. (N = 3).

b

Below LOQbrain = 5nM.